Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04821375 · ClinicalTrials.gov registry record · Early Phase 1
Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers
A Early Phase 1 study, sponsored by Carol Fabian, MD.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 16
- Enrollment target
NCT04821375 is a Early Phase 1 study that has completed, run by Carol Fabian, MD. The registered enrollment target is 16 participants.
The verdict
NCT04821375, a Early Phase 1 study, has completed, sponsored by Carol Fabian, MD.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
Pilot study to test feasibility of 6 months of bazedoxifene (BZA) plus conjugated estrogens (CE) to modulate breast MRI parameters.
Interventions
- DRUG bazedoxifene plus conjugated estrogens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-12-02 |
| Est. Completion | 2024-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04821375
The ClinicalTrials.gov registry entry for NCT04821375 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carol Fabian, MD, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which bazedoxifene plus conjugated estrogens is the first listed.
NCT04821375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04821375 about?
NCT04821375 is a clinical study titled "Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers". Pilot study to test feasibility of 6 months of bazedoxifene (BZA) plus conjugated estrogens (CE) to modulate breast MRI parameters.
What is the current status of trial NCT04821375?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 16 participants. The study started on 2021-12-02. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT04821375?
The interventions under investigation include: bazedoxifene plus conjugated estrogens (DRUG).
Who is sponsoring clinical trial NCT04821375?
This trial is sponsored by Carol Fabian, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.